Cardlytics
CDLX
58 hedge funds and large institutions have $299M invested in Cardlytics in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 8 reducing their positions, and 11 closing their positions.
238% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 8
102% more capital inflows, than outflows
Capital inflows: $76.7M | Capital outflows: $37.9M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
9% more funds holding
Funds holding: 53 → 58 (+5)
6.06% more ownership
Funds ownership: 49.67% → 55.73% (+6.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$28M |
| 2 |
Frontier Capital Management
Boston,
Massachusetts
|
+$10.4M |
| 3 |
SRFM
Shannon River Fund Management
New York
|
+$8.53M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.14M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$3.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Discovery Capital Management
South Norwalk,
Connecticut
|
-$25.5M |
| 2 |
G2 Investment Partners Management
New York
|
-$4.05M |
| 3 |
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$1.8M |
| 4 |
EAM Global Investors
Solana Beach,
California
|
-$1.14M |
| 5 |
Millennium Management
New York
|
-$1.11M |
CDLX Hedge Fund Activity: Q3 2018 in Review
58 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q3 2018, worth a combined $299M — up 38% from $217M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CDLX positions and 11 closed out — a net gain of 5 holders — while 27 added to existing stakes and 8 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $28M. The largest seller was Discovery Capital Management, cutting an estimated $25.5M.
- 58 institutional investors held Cardlytics (CDLX) as of Q3 2018, up from 53 in Q2 2018.
- Funds reported $299M of Cardlytics stock for Q3 2018, up 38% quarter-over-quarter.
- 16 funds opened new Cardlytics positions in Q3 2018 and 11 closed out, a net change of +5 holders.
- The largest Cardlytics buyer in Q3 2018 was Fidelity Investments, an estimated $28M added.
- The largest Cardlytics seller in Q3 2018 was Discovery Capital Management, an estimated $25.5M sold.
Based on aggregated 13F filings for Q3 2018.